(Q30924125)

English

Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin (English)

1 reference

Europe PubMed Central

19 August 2017

1 reference

based on heuristic

inferred from title

Robert J. Linhardt

5

object named as

R Linhardt

1 reference

Europe PubMed Central

19 August 2017

author name string

Z Shriver

1

1 reference

Europe PubMed Central

19 August 2017

M Sundaram

2

1 reference

Europe PubMed Central

19 August 2017

G Venkataraman

3

1 reference

Europe PubMed Central

19 August 2017

J Fareed

4

1 reference

Europe PubMed Central

19 August 2017

K Biemann

6

1 reference

Europe PubMed Central

19 August 2017

R Sasisekharan

7

1 reference

Europe PubMed Central

19 August 2017

language of work or name

0 references

publication date

1 September 2000

1 reference

Europe PubMed Central

19 August 2017

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

19 August 2017

97

1 reference

Europe PubMed Central

19 August 2017

10365-10370

1 reference

Europe PubMed Central

19 August 2017

19

1 reference

Europe PubMed Central

19 August 2017

Sequencing of 3-O sulfate containing heparin decasaccharides with a partial antithrombin III binding site

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27030

21 June 2018

In vitro studies on the biochemistry and pharmacology of low molecular weight heparins.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27030

21 June 2018

Production and chemical processing of low molecular weight heparins.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27030

21 June 2018

Sequencing complex polysaccharides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27030

21 June 2018

Structural features and anticoagulant activities of a novel natural low molecular weight heparin from the shrimp Penaeus brasiliensis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27030

21 June 2018

Synthesis of thrombin-inhibiting heparin mimetics without side effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27030

21 June 2018

Ex vivo evaluation of a Taylor-Couette flow, immobilized heparinase I device for clinical application

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27030

21 June 2018

Mass spectrometric evidence for the enzymatic mechanism of the depolymerization of heparin-like glycosaminoglycans by heparinase II.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27030

21 June 2018

Direct evidence for a predominantly exolytic processive mechanism for depolymerization of heparin-like glycosaminoglycans by heparinase I.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27030

21 June 2018

Mass spectrometric and capillary electrophoretic investigation of the enzymatic degradation of heparin-like glycosaminoglycans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27030

21 June 2018

Mechanism of heparin activation of antithrombin. Role of individual residues of the pentasaccharide activating sequence in the recognition of native and activated states of antithrombin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27030

21 June 2018

Heparin-induced thrombocytopenia: towards consensus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27030

21 June 2018

Enzymatic preparation of heparin oligosaccharides containing antithrombin III binding sites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27030

21 June 2018

Enzymatic degradation of glycosaminoglycans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27030

21 June 2018

Structural studies on the bacterial lyase-resistant tetrasaccharides derived from the antithrombin III-binding site of porcine intestinal heparin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=27030

21 June 2018

Management of oral anticoagulant therapy in Italy

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.19.10365

21 January 2018

Pharmacokinetic and pharmacodynamic properties of oral anticoagulants, especially phenprocoumon

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.19.10365

21 January 2018

Deconvolution of the fluorescence emission spectrum of human antithrombin and identification of the tryptophan residues that are responsive to heparin binding.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.19.10365

21 January 2018

The separation of active and inactive forms of heparin

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.19.10365

21 January 2018

Laboratory monitoring of pentasaccharide in a dog model of hemodialysis

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.19.10365

21 January 2018

Regional heparinization via simultaneous separation and reaction in a novel Taylor-Couette flow device

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.19.10365

21 January 2018

Investigation of a whole blood fluidized bed Taylor-Couette flow device for enzymatic heparin neutralization

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.97.19.10365

21 January 2018

Ex-vivo and in-vitro evidence that low molecular weight heparins exhibit less binding to plasma proteins than unfractionated heparin

1 reference

https://pubmed.ncbi.nlm.nih.gov/10984532

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.97.19.10365

1 reference

Europe PubMed Central

19 August 2017

2000PNAS...9710365S

0 references

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30924125&oldid=1584901216"